The bottom mixed layer depth as an indicator of subsurface Chlorophyll a distribution

Acknowledgements The authors thank Marine Scotland Science for providing the CTD data. Financial support This research has been supported by a MarCRF (Marine Collaboration Research Forum, jointly sponsored by the University of Aberdeen and Marine Scotland Science) PhD grant awarded to Arianna Zampollo.Peer reviewedPublisher PD

The Cooperative Participatory Evaluation of Renewable Technologies on Ecosystem Services (CORPORATES)

Publisher PD

Nest-building males trade-off material collection costs with territory value

This work was supported by the BBSRC (BB/I019502/1 to SDH and SLM) and Roslin Institute Strategic Grant funding from the BBSRC (SLM).Building a structurally robust nest is crucial for reproductive success in many birds. However, we know little about the criteria birds use to select material or where they go to collect it. Here we observed the material collection of male Cape Weavers (Ploceus capensis). Males typically selected long, strong material to build their nests and each male collected material from different locations. Males that built more nests nested in a different area of the colony and flew further to collect nest material than did males that built fewer nests. As these males that flew further to collect material had longer tails and wings and attracted more females to their territories than did males that flew shorter distances, they may have traded off the travel costs of collecting nest materials with benefits gained from holding a territory in a more 'desirable' part of the colony. Nest construction, then, appears to be a multi-dimensional task whereby birds take into account material's structural properties, material proximity to the nest site and territory quality. Males that do this effectively both attract more mates and provide structurally sound nests for their young.Publisher PDFPeer reviewe

Combination Therapies Targeting Alk-Aberrant Neuroblastoma in Preclinical Models.

BACKGROUND: ALK activating mutations are identified in approximately 10% of newly diagnosed neuroblastomas and ALK amplifications in a further 1-2% of cases. Lorlatinib, a third generation ALK inhibitor, will soon be given alongside induction chemotherapy for children with ALK-aberrant neuroblastoma. However, resistance to single agent treatment has been reported and therapies that improve the response duration are urgently required. We studied the preclinical combination of lorlatinib with chemotherapy, or with the MDM2 inhibitor, idasanutlin, as recent data has suggested that ALK inhibitor resistance can be overcome through activation of the p53-MDM2 pathway. AIMS: To study the preclinical activity of ALK inhibitors alone and combined with chemotherapy or idasanutlin. METHODS: We compared different ALK inhibitors in preclinical models prior to evaluating lorlatinib in combination with chemotherapy or idasanutlin. We developed a triple chemotherapy (CAV: cyclophosphamide, doxorubicin and vincristine) in vivo dosing schedule and applied this to both neuroblastoma genetically engineered mouse models (GEMM) and patient derived xenografts (PDX). RESULTS: Lorlatinib in combination with chemotherapy was synergistic in immunocompetent neuroblastoma GEMM. Significant growth inhibition in response to lorlatinib was only observed in the ALK-amplified PDX model with high ALK expression. In this PDX lorlatinib combined with idasanutlin resulted in complete tumor regression and significantly delayed tumor regrowth. CONCLUSION: In our preclinical neuroblastoma models, high ALK expression was associated with lorlatinib response alone or in combination with either chemotherapy or idasanutlin. The synergy between MDM2 and ALK inhibition warrants further evaluation of this combination as a potential clinical approach for children with neuroblastoma

Як уникнути підйому рівня води?

East Africa’s Lake Victoria provides resources and services to millions of people on the lake’s shores and abroad. In particular, the lake’s fisheries are an important source of protein, employment, and international economic connections for the whole region. Nonetheless, stock dynamics are poorly understood and currently unpredictable. Furthermore, fishery dynamics are intricately connected to other supporting services of the lake as well as to lakeshore societies and economies. Much research has been carried out piecemeal on different aspects of Lake Victoria’s system; e.g., societies, biodiversity, fisheries, and eutrophication. However, to disentangle drivers and dynamics of change in this complex system, we need to put these pieces together and analyze the system as a whole. We did so by first building a qualitative model of the lake’s social-ecological system. We then investigated the model system through a qualitative loop analysis, and finally examined effects of changes on the system state and structure. The model and its contextual analysis allowed us to investigate system-wide chain reactions resulting from disturbances. Importantly, we built a tool that can be used to analyze the cascading effects of management options and establish the requirements for their success. We found that high connectedness of the system at the exploitation level, through fisheries having multiple target stocks, can increase the stocks’ vulnerability to exploitation but reduce society’s vulnerability to variability in individual stocks. We describe how there are multiple pathways to any change in the system, which makes it difficult to identify the root cause of changes but also broadens the management toolkit. Also, we illustrate how nutrient enrichment is not a self-regulating process, and that explicit management is necessary to halt or reverse eutrophication. This model is simple and usable to assess system-wide effects of management policies, and can serve as a paving stone for future quantitative analyses of system dynamics at local scales

Harmful algal blooms along the North American west coast region: History, trends, causes, and impacts

Along the Pacific coast of North America, from Alaska to Mexico, harmful algal blooms (HABs) have caused losses to natural resources and coastal economies, and have resulted in human sicknesses and deaths for decades. Recent reports indicate a possible increase in their prevalence and impacts of these events on living resources over the last 10–15 years. Two types of HABs pose the most significant threat to coastal ecosystems in this “west coast” region: dinoflagellates of the genera Alexandrium, Gymnodinium, and Pyrodinium that cause paralytic shellfish poisoning (PSP) and diatoms of the genus Pseudo-nitzschia that produce domoic acid (DA), the cause of amnesic shellfish poisoning (ASP) in humans. These species extend throughout the region, while problems from other HABs (e.g., fish kills linked to raphidophytes or Cochlodinium, macroalgal blooms related to invasive species, sea bird deaths caused by surfactant-like proteins produced by Akashiwo sanguinea, hepatotoxins from Microcystis, diarrhetic shellfish poisoning from Dinophysis, and dinoflagellate-produced yessotoxins) are less prevalent but potentially expanding. This paper presents the state-of-knowledge on HABs along the west coast as a step toward meeting the need for integration of HAB outreach, research, and management efforts.Keywords: Alexandrium, Harmful algal blooms, Pseudo-nitzschia, Domoic acid, Paralytic shellfish poisoning, Heterosigm

Enithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts

Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. No active systemic agents are currently approved specifically for EHE, which is typically refractory to the antitumor drugs used in sarcomas. The degree of uncertainty in selecting the most appropriate therapy for EHE patients and the lack of guidelines on the clinical management of the disease make the adoption of new treatments inconsistent across the world, resulting in suboptimal outcomes for many EHE patients. To address the shortcoming, a global consensus meeting was organized in December 2020 under the umbrella of the European Society for Medical Oncology (ESMO) involving >80 experts from several disciplines from Europe, North America and Asia, together with a patient representative from the EHE Group, a global, disease-specific patient advocacy group, and Sarcoma Patient EuroNet (SPAEN). The meeting was aimed at defining, by consensus, evidence-based best practices for the optimal approach to primary and metastatic EHE. The consensus achieved during that meeting is the subject of the present publication.Peer reviewe